Skip to content
10-Q

Quarterly Report

BIONOVATE TECHNOLOGIES CORP.

0001640334-20-000443

← back to feed
Filed
Mar 2, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2020 · Feb 18, 2020 54.43M sh
Current Liabilities Q2 2020 · Dec 31, 2019 $387.82K
Current Liabilities Q2 2020 · Jun 30, 2019 $332.29K
Total Liabilities Q2 2020 · Dec 31, 2019 $387.82K
Total Liabilities Q2 2020 · Jun 30, 2019 $332.29K
Stockholders Equity Q2 2020 · Dec 31, 2018 −$281.7K
Stockholders Equity Q2 2020 · Sep 30, 2018 −$251.67K
Stockholders Equity Q2 2020 · Jun 30, 2018 −$309.68K
Sga Expense Q2 2020 · Dec 31, 2018 $4.93K
Net Income Q2 2020 · Dec 31, 2018 −$47.33K
Net Income Q2 2020 · Dec 31, 2018 −$134.84K
Operating Income Q2 2020 · Dec 31, 2018 −$18.34K
Operating Income Q2 2020 · Dec 31, 2018 −$33.44K